NASDAQ: ENTXEntera Bio Ltd Stock Ownership - Who owns Entera Bio?
Insider buying vs selling
Have Entera Bio Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Geno J. Germano | Director | 2026-03-09 | 20,000 | $1.30 | $26.00kBuy |
| Sean Ellis | Director | 2026-03-05 | 10,000 | $1.23 | $12.30kBuy |
| Steven D. Rubin | Director | 2026-02-12 | 5,000 | $1.49 | $7.45kBuy |
| Haya Taitel | Director | 2026-02-10 | 7,500 | $1.48 | $11.10kBuy |
| Geno J. Germano | Director | 2026-02-10 | 20,000 | $1.49 | $29.80kBuy |
| Sean Ellis | Director | 2026-02-09 | 18,000 | $1.24 | $22.32kBuy |
| Steven D. Rubin | Director | 2026-02-09 | 10,000 | $1.20 | $12.00kBuy |
| Miranda Jayne Toledano | Chief Executive Officer | 2025-12-29 | 11,000 | $1.81 | $19.91kBuy |
ENTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ENTX insiders and whales buy or sell their stock.
ENTX Shareholders
What type of owners hold Entera Bio Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Knoll Capital Management LLC | 11.95% | 5,881,879 | $7.41M | Institution |
| Knoll Capital Management LLC | 11.24% | 5,534,275 | $6.97M | Insider |
| Phillip Schwartz | 1.23% | 607,410 | $765.34k | Insider |
| Renaissance Technologies LLC | 0.96% | 473,442 | $596.54k | Institution |
| Miranda Jayne Toledano | 0.87% | 426,575 | $537.48k | Insider |
| Gerald M. Lieberman | 0.70% | 344,654 | $434.26k | Insider |
| Parkman Healthcare Partners LLC | 0.59% | 288,670 | $363.72k | Institution |
| Dana Yaacovgarbeli | 0.52% | 258,172 | $325.30k | Insider |
| Citadel Advisors LLC | 0.50% | 245,577 | $309.43k | Institution |
| Seven Fleet Capital Management LP | 0.42% | 205,542 | $258.98k | Institution |
ENTX vs Biotech Stocks
Entera Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.